MeiraGTx Holdings (MGTX) | Stock Overview & Key Data
MeiraGTx Holdings Performance Comparison
Stock Range
Today's Range
Low: $8.02
High: $8.25
on July 29, 2025
52 Week Range
Low: $3.85
High: $8.98
on September 3, 2024
on July 15, 2025
All-Time High: $30.23 on July 8, 2019
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$650.6M
EPS
-2.31
P/E Ratio (TTM)
-3.75
Forward P/E
9.75
P/B Ratio
19.41
PEG Ratio
9.75
Div. Yield
N/A
ROE
-216.14%
Beta
1.245
Debt to Equity
244.35
Financial Highlights
Profitability
Gross Margin
28.45%
Operating Margin
-2,159.71%
Profit Margin
28.51%
Returns and Earnings
Return on Assets (TTM)
-37.28%
Return on Equity (TTM)
-216.14%
EBITDA
$-146.4M
Net Income (TTM)
$-167.3M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$0.44
Quarterly Revenue Growth (YoY)
176.30%
Quarterly Earnings Growth (YoY)
176.33%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| MeiraGTx Holdings MGTX | 650.56M Small-cap | -6.05% | 23.77% | 16.96% | 29.74% | 28.71% | 68.83% | -22.03% | -41.52% |
| Vertex VRTX | 120.60B Large-cap | -0.37% | 5.21% | -6.97% | 6.09% | 15.44% | -5.27% | 62.63% | 71.59% |
| Regeneron REGN | 60.80B Large-cap | -0.50% | 6.31% | -1.89% | -18.79% | -21.96% | -48.42% | -9.04% | -10.01% |
| Cg Oncology CGON | 1.93B Small-cap | 0.12% | 0.15% | -3.34% | -14.03% | -10.11% | -20.12% | -25.66% | -25.66% |
| Denali Therapeutics DNLI | 1.99B Small-cap | -1.87% | -2.72% | -17.52% | -41.86% | -34.69% | -37.77% | -61.93% | -56.94% |
| Ocular Therapeutix OCUL | 1.95B Small-cap | 1.73% | 26.62% | 43.12% | 49.87% | 34.44% | 51.03% | 136.90% | 43.12% |
Ownership & Short Interest
Insider Ownership
24.17%
Institutional Ownership
59.86%
Shares Short
4M
Short Ratio
6.49
Short % of Shares Outstanding
6.86%
Average 10-Day Volume
426K
Average 90-Day Volume
507K
MeiraGTx Holdings Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in MeiraGTx Holdings would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is MGTX's 52-week high and low?
- In the last 52 weeks, MeiraGTx Holdings reached a high of $8.98 (on July 15, 2025) and a low of $3.85 (on September 3, 2024).
- What is the market cap and P/E ratio for MGTX?
- Curious about MeiraGTx Holdings's size and valuation? Its market capitalization stands at 650.56M. When it comes to valuation, the P/E ratio (trailing twelve months) is -3.75, and the forward P/E (looking ahead) is 9.75.
- Does MGTX pay dividends? If so, what's the yield?
- As for dividends, MeiraGTx Holdings isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are MeiraGTx Holdings's main competitors or similar companies to consider before investing?
When looking at MeiraGTx Holdings, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Vertex
VRTX120.60B Healthcare Biotechnology -5.27% 62.63% Regeneron
REGN60.80B Healthcare Biotechnology -48.42% -9.04% Cg Oncology
CGON1.93B Healthcare Biotechnology -20.12% -25.66% Denali Therapeutics
DNLI1.99B Healthcare Biotechnology -37.77% -61.93% Ocular Therapeutix
OCUL1.95B Healthcare Biotechnology 51.03% 136.90% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for MeiraGTx Holdings plc? (e.g., ROE, Debt/Equity)
- To get a sense of MeiraGTx Holdings's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -216.14%, the Debt to Equity ratio from the most recent quarter is 244.35, and its Gross Profit Margin stands at 28.45%.
- What is the recent revenue and earnings growth for MGTX?
- Looking at MeiraGTx Holdings's growth, its revenue over the trailing twelve months (TTM) was $35M. Compared to the same quarter last year (YoY), quarterly revenue grew by 176.30%, and quarterly earnings saw a YoY growth of 176.33%.
- How much of MGTX stock is held by insiders and institutions?
- Wondering who owns MeiraGTx Holdings stock? Company insiders (like executives and directors) hold about 24.17% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 59.86%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.